Skip to main content

Neuroone Medical Technologies Corp

NMTC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001500198

In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Neuroone Medical Technologies Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
+6 vs. Q2 2021
Shares held
1.25M
+21.6K (+1.8%) vs. Q2 2021
Total value
$4.94M
−$3.21M (−39.4%) vs. Q2 2021
New holders
7
0 more added
Sold out
1
0 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NMTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 9 institutions
Q1 2021: 0 institutionsQ2 2021: 4 institutionsQ3 2021: 9 institutionsQ4 2021: 17 institutionsQ1 2022: 12 institutionsQ2 2022: 11 institutionsQ3 2022: 12 institutionsQ4 2022: 21 institutionsQ1 2023: 16 institutionsQ2 2023: 15 institutionsQ3 2023: 20 institutionsQ4 2023: 21 institutionsQ1 2024: 19 institutionsQ2 2024: 19 institutionsQ3 2024: 22 institutionsQ4 2024: 21 institutionsQ1 2025: 19 institutionsQ2 2025: 31 institutionsQ3 2025: 34 institutionsQ4 2025: 37 institutionsQ1 2026: 32 institutionsQ2 2026: 26 institutions
Value heldQ3 2021: $4.94M
Q1 2021: $0Q2 2021: $9.36MQ3 2021: $4.94MQ4 2021: $6.52MQ1 2022: $2.33MQ2 2022: $1.51MQ3 2022: $2.99MQ4 2022: $1.53MQ1 2023: $2.44MQ2 2023: $1.79MQ3 2023: $3.71MQ4 2023: $6.81MQ1 2024: $5.16MQ2 2024: $2.95MQ3 2024: $3.59MQ4 2024: $2.30MQ1 2025: $2.63MQ2 2025: $9.80MQ3 2025: $12.8MQ4 2025: $9.44MQ1 2026: $9.14MQ2 2026: $6.21M
Institutions holding NMTC and their total value by quarter
QuarterHoldersValue
Q2 202626$6.21M
Q1 202632$9.14M
Q4 202537$9.44M
Q3 202534$12.8M
Q2 202531$9.80M
Q1 202519$2.63M
Q4 202421$2.30M
Q3 202422$3.59M
Q2 202419$2.95M
Q1 202419$5.16M
Q4 202321$6.81M
Q3 202320$3.71M
Q2 202315$1.79M
Q1 202316$2.44M
Q4 202221$1.53M
Q3 202212$2.99M
Q2 202211$1.51M
Q1 202212$2.33M
Q4 202117$6.52M
Q3 20219$4.94M
Q2 20214$9.36M
Q1 20210$0

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Neuroone Medical Technologies Corp; share changes are against Q2 2021.

Institutions holding NMTC in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
AWM Investment Company, Inc.1,000,001$3.95M0.39%00.0%Unchanged
Millennium Management LLC106,151$419.0K0.00%+106,151New
Intersect Capital LLC50,000$198.0K0.03%+50,000New
Premier Asset Management LLC50,000$197.0K0.03%00.0%Unchanged
HRT Financial LP39,175$154.0K0.00%+39,175New
Tower Research Capital LLC (TRC)4,907$20.0K0.00%+4,907New
Cutler Group LP500$1.00K0.00%+500New
Meridian Wealth Partners, LLC200$1.00K0.00%+200New
Wells Fargo & Company54$00.00%+54New
Baker Avenue Asset Management, LP0$00.00%−179,370−100.0%Sold out
Mayo Clinic––––Not filed